Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$52.13 - $93.81 $2.05 Million - $3.68 Million
-39,268 Reduced 14.13%
238,595 $16.2 Million
Q1 2022

May 16, 2022

BUY
$64.92 - $99.47 $18 Million - $27.6 Million
277,863 New
277,863 $25.2 Million
Q2 2021

Aug 16, 2021

SELL
$79.62 - $114.85 $12.7 Million - $18.3 Million
-159,432 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$77.91 - $125.92 $1.74 Million - $2.82 Million
-22,371 Reduced 12.31%
159,432 $17.1 Million
Q4 2020

Feb 16, 2021

BUY
$60.0 - $87.29 $10.9 Million - $15.9 Million
181,803 New
181,803 $15.9 Million
Q3 2020

Nov 16, 2020

SELL
$47.53 - $82.76 $2.85 Million - $4.97 Million
-60,000 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$42.51 - $52.46 $2.55 Million - $3.15 Million
60,000 New
60,000 $2.91 Million

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $2.96B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Summit Partners Public Asset Management, LLC Portfolio

Follow Summit Partners Public Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Partners Public Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Partners Public Asset Management, LLC with notifications on news.